Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: an analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database

Ghezelayagh, Talayeh

406
Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: an analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

T. Ghezelayagh^1,2, J. A. Rauh-Hain³ and W. B. Growdon³
¹Harvard School of Public Health, Boston, MA, ²UCSF School of Medicine, San Francisco, CA, ³Massachusetts General Hospital/Harvard University, Boston, MA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

406
Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: an analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database

406 Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: an analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database

406
Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: an analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database